Y-Intercept (HK)’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Y-Intercept (HK)’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-6,928	Closed	-$521K	–	1379
2022 Q2	$521K	Buy	+6,928	New	+$308K	0.07%	416

Y-Intercept (HK)'s TPTX Position: Q3 2022 in Review

Y-Intercept (HK) sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 6,928 shares — an estimated $521K sold.

Y-Intercept (HK) first reported a position in TPTX in Q2 2022 and held it in 1 quarter. The position peaked at $521K in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

Y-Intercept (HK) reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Y-Intercept (HK) sold 6,928 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $521K.
Y-Intercept (HK) first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
Y-Intercept (HK)'s Turning Point Therapeutics, Inc. Common Stock position peaked at $521K in Q2 2022.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Y-Intercept (HK)'s 13F filing for Q3 2022, filed 14 Feb 2023.